HEALTHAL JAZEERA
GLP-1s are changing US healthcare, should everyone be on them?
GLP-1 drugs, originally developed to treat diabetes, are now widely used for obesity and are reshaping healthcare in the US.
Related Signal
Adjacent reporting
- The promises and pitfalls of GLP-1 drugs
- Should everyone be on GLP-1s? What the science really tells us about cancer prevention and other benefits
- GLP-1 use reaches new high in US
- The promises and pitfalls of GLP-1 drugs
- GLP-1 insurance change impacts millions of Americans: What to know, how to tell if you’re covered